Drug intelligence / Profile preview

sodium r-alpha-lipoate

Development stage
Preclinical
Lead developer
GeroNova Research
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Sodium r-alpha-lipoate (also known as sodium R-alpha-lipoate or Na-RALA) is a highly stable and bioavailable sodium salt form of R-alpha-lipoic acid (R-ALA), a naturally occurring organosulfur compound and potent antioxidant. Unlike free R-lipoic acid, which is highly unstable and prone to polymerization, the sodium salt form exhibits significantly enhanced water solubility, stability, and pharmacokinetic absorption, achieving much higher plasma concentrations in humans. It acts as a cofactor for key mitochondrial multienzyme complexes (such as pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase) involved in energy metabolism, and functions as a direct and indirect antioxidant by scavenging reactive oxygen species, chelating transition metals, and regenerating other endogenous antioxidants like glutathione, vitamin C, and vitamin E. It is developed and manufactured by companies such as Shandong Jincheng Pharmaceutical Group and GeroNova Research, primarily as a nutraceutical/dietary supplement and pharmaceutical ingredient for the potential treatment of diabetic neuropathy, oxidative stress-related conditions, and cognitive decline.

Brand names
Bio-Enhanced Na-RALA
Other names
Na-RALANaRLAR-ALA sodium saltR-alpha-lipoic acid sodium saltR-α-硫辛酸钠sodium (R)-5-(1,2-dithiolan-3-yl)pentanoatesodium (R)-alpha-lipoatesodium R-alpha-lipoatesodium R-lipoatesodium R-thioctate
02

Targets

BCKDH complex (Branched-chain alpha-keto acid dehydrogenase complex)PDK (Pyruvate dehydrogenase kinase isoform 1)α-KGDH (Alpha-ketoglutarate dehydrogenase complex)PDH (Pyruvate dehydrogenase complex)

Beyond the preview

Go deeper on sodium r-alpha-lipoate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium r-alpha-lipoate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call